SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Alector, Inc. (NASDAQ:ALEC)

US · Delayed Price · Currency is USD
1.97+0.04 (+2.34%)
 
Market Cap218.16M-36.2%
Revenue (ttm)13.86M-82.9%
Net Income-117.85M-2.2%
EPS-1.10+5.3%
Shares Out111.03M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume647,229
Open1.90
Previous Close1.92
Day's Range1.89 - 1.97
52-Week Range1.09 - 3.40
Beta0.62
AnalystsBuy
Price Target2.25(+14.50%)
Earnings DateNov 5, 2026
+2.60% (1D)
No price history available.
Insider Score
––Not scored
ALEC Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

About ALEC

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Address
131 Oyster Point Boulevard, South San Francisco, CA, 94080, US
Market Cap
218 million
Employees
103
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$729.76K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+2.34%
5 Days
+3.97%
1 Month
-20.45%
6 Months
-18.80%
1 Year
-36.20%

$ALEC stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ALEC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ALEC's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ALEC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ALEC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ALEC from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ALEC

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$6.41M
IWMiShares Russell 2000 ETF$4.99M
VXFVanguard Extended Market ETF$2.42M
IWOiShares Russell 2000 Growth ETF$1.59M
VTWOVanguard Russell 2000 ETF$1.27M
SCHASchwab U.S. Small-Cap ETF$899.22K

Estimated from each fund’s disclosed top holdings × AUM

ALEC Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for ALEC is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from ALEC’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
14
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.